<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04018066</url>
  </required_header>
  <id_info>
    <org_study_id>Pro2018002579</org_study_id>
    <nct_id>NCT04018066</nct_id>
  </id_info>
  <brief_title>The Effect of Concord Grape Polyphenol-soy Protein Isolate Complex (GP-SPI) on Gut Microbiota</brief_title>
  <official_title>The Effect of Concord Grape Polyphenol-soy Protein Isolate Complex (GP-SPI) on Gut Microbiota</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rutgers, The State University of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rutgers, The State University of New Jersey</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall purpose of this study is to evaluate the effect of nutritional supplementation&#xD;
      with a well-characterized preparation of Concord grape polyphenol-soy protein isolate&#xD;
      (GP-SPI) on the composition of the gut microbiota.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed study will investigate how short-term supplementation with GP-SPI may modify the&#xD;
      gut microbial community in healthy participants while monitoring liver and kidney&#xD;
      function/health.&#xD;
&#xD;
      Significance:&#xD;
&#xD;
      Biochemical properties of the GP-SPI food ingredient are well-documented and GP-SPI and SPI&#xD;
      supplements have been tested extensively in mice. The proposed study is a logical follow up&#xD;
      to animal studies, which showed that compared to control mice fed a high-fat diet (HFD)&#xD;
      supplemented with SPI alone, mice fed an isocaloric HFD supplemented with GP-SPI exhibited&#xD;
      greater resistance to weight gain, adiposity, and glucose intolerance. These effects were&#xD;
      accompanied by changes in murine gut microbiota composition, including increased abundance of&#xD;
      the microbe Akkermansia muciniphila, associated with metabolic resilience. Similar gut&#xD;
      microbiota changes were observed in lean mice fed low-fat diet (LFD) supplemented with&#xD;
      GP-SPI.&#xD;
&#xD;
      The B-type proanthocyanidin (PAC) class of polyphenols contained in grape berries, especially&#xD;
      skins and seeds, have been associated with health benefits; however, PACs are poorly absorbed&#xD;
      and reach high concentration only in the colon raising questions about mechanism(s) of&#xD;
      action. Prior studies showed that dietary PACs from grape and cranberry alter the gut&#xD;
      microbiota in association with metabolic resilience. PACs are also biotransformed by gut&#xD;
      bacteria to yield microbial metabolites (MMs) that may contribute to health benefits.&#xD;
&#xD;
      Research Design and Methods&#xD;
&#xD;
      Prospective participants will be recruited through flyers posted locally on Rutgers&#xD;
      University campuses and sent to university email lists. Interested persons will be screened&#xD;
      according to inclusion and exclusion criteria.&#xD;
&#xD;
      Enrolled subjects will begin the 17-day study.&#xD;
&#xD;
      Study Procedures&#xD;
&#xD;
        -  Thirty subjects will be enrolled.&#xD;
&#xD;
        -  Food List: Participants will maintain their usual diet except for a provided list of&#xD;
           PAC-rich foods that they will be asked to abstain from for a 5-day wash-out period and&#xD;
           during the 10-day intervention. The Food List is provided below. The goal is to have&#xD;
           GP-SPI as the main/only source of PAC in the diet for the study period.&#xD;
&#xD;
        -  Wash-out and SPI (Day -5 through -1): On day -5 (pre-baseline) before any&#xD;
           supplementation, each subject will collect their fecal and urine sample. Each subject&#xD;
           will then consume SPI twice a day (provided as pre-weighed packets of 20 g) during a&#xD;
           5-day wash-out period (days -5, -4, -3, -2, and -1). Subjects will be instructed to mix&#xD;
           each packet of SPI in 250 mL of water or in a smoothie (recipe example below will be&#xD;
           provided) using allowed foods as detailed in instructions and consume once in the&#xD;
           morning before breakfast and once in the evening before dinner.&#xD;
&#xD;
        -  Day 0: On the following day each subject will collect their baseline (day 0) stool and&#xD;
           urine samples. They will have a blood sample drawn by a study nurse. Blood will be used&#xD;
           for CMP test and prepared serum will be aliquoted and stored at -80 °C until processing&#xD;
           for marker analysis and metabolomics. Analysis of day 0 samples should help isolate any&#xD;
           effects due to SPI alone from subsequent samples collected during GP-SPI intervention.&#xD;
           On day 0 subjects will drop off urine and stool samples at IFNH and collect GP-SPI&#xD;
           packets. On Day 0 participants will also take a break from consuming SPI and will start&#xD;
           GP-SPI supplementation on morning of Day 1.&#xD;
&#xD;
        -  GP-SPI (Day 1 - 10): Each subject will receive twenty pre-weighed 20 g packets of&#xD;
           GP-SPI. On day 1 subjects will be instructed to mix each packet of GP-SPI in 250 mL of&#xD;
           water or in smoothie (recipe example will be provided, please see below) using allowed&#xD;
           foods as detailed in instructions and consume the GP-SPI mix once in the morning before&#xD;
           breakfast and once in the evening before dinner for 10 consecutive days.&#xD;
&#xD;
        -  Subjects will be provided with a personal blender for smoothie preparation (value ~ $25)&#xD;
           that they can keep.&#xD;
&#xD;
        -  Digital food diary: Participants will be asked to take photos of all their food and&#xD;
           drink (except water) including the study supplements with their personal mobile&#xD;
           computing device (e.g. smart phone, iPad, or similar). Participants will be required to&#xD;
           download the free mobile app WhatsApp to send photos with a brief description of the&#xD;
           food items. Photos and food description may also be sent to an email address created for&#xD;
           this study (food4microbes@sebs.rutgers.edu). The food diary must be kept over the 5-day&#xD;
           SPI and wash-out period, day 0 (break day), the 10-day GP-SPI intervention period, and&#xD;
           up until the final blood draw on day 11 (17 days total).&#xD;
&#xD;
        -  Stool samples: Subjects will be provided with tubes containing 95% ethanol and/or tubes&#xD;
           containing 50% glycerol (50% water) along with paper toilet accessories for easy&#xD;
           self-collection of fecal samples; each participant will be instructed on use of stool&#xD;
           collection materials. Fecal samples will be aliquoted and stored at -80 °C until&#xD;
           extraction. Collection of fecal samples in 50% glycerol and immediate freezing will&#xD;
           allow culturing of gut bacteria for in vitro experiments.&#xD;
&#xD;
        -  Bristol stool scale form: Subjects will be provided with the Bristol stool scale (BSS)&#xD;
           form and asked to complete it for stool samples they collect on days -5, 0, 2, 4, 6, 8,&#xD;
           and 10 of the study. Stool consistency has been shown to strongly correlate with gut&#xD;
           microbiota richness and composition, enterotypes, and bacterial growth rates. Subjects&#xD;
           that report at least one bowel movement per day will be recruited for ease of compliance&#xD;
           with study protocol. In addition, the BSS form contains an extra column to capture&#xD;
           information about menstruation during time of sample collections as this variable could&#xD;
           impact metabolite or bacteria profiles .&#xD;
&#xD;
        -  Urine samples: Subjects will be provided with sterile collection containers for&#xD;
           collection of urine samples on days 2, 4, 6, 8, 10 and asked to keep samples in 4 °C&#xD;
           fridge until transport to the laboratory to maintain metabolite stability. Subjects will&#xD;
           be asked to bring their samples to the laboratory as soon as possible, within 2-3 days&#xD;
           of collection, for processing. Urine samples will be aliquoted and stored at -80 °C&#xD;
           until processing for metabolomics studies.&#xD;
&#xD;
        -  Blood sample: On day 11 subjects will have a final blood sample drawn. Blood will be&#xD;
           used for CMP test and prepared serum will be aliquoted and stored at -80 °C until&#xD;
           processing for marker analysis and metabolomics.&#xD;
&#xD;
      Samples will be used for a longitudinal, microbiome-wide association study (MWAS) to identify&#xD;
      gut bacteria species/strains that are positively or negatively associated with GP-SPI&#xD;
      supplementation. Metabolomics analysis will be performed on collected urine, fecal, and blood&#xD;
      samples to identify/quantify known and unknown metabolites. Shotgun metagenomic sequencing&#xD;
      will be performed on fecal samples to generate high quality draft genomes for species/strain&#xD;
      level identification. These dynamic data sets will serve as input for the MWAS to correlate&#xD;
      increasing/decreasing levels of gut bacterial species/strains to increasing/decreasing&#xD;
      metabolites. These bacteria-metabolite associations will then be used to infer cause-effect&#xD;
      relationships that can be further tested in vitro and in mouse models. We expect that&#xD;
      successful completion of these studies will contribute to mechanistic explanations for how&#xD;
      dietary polyphenols such as grape PACs alter the gut microbiota and resulting MM to promote&#xD;
      metabolic health.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 28, 2019</start_date>
  <completion_date type="Actual">December 20, 2019</completion_date>
  <primary_completion_date type="Actual">December 20, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Longitudinal study</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gut Microbiota Composition</measure>
    <time_frame>16S rRNA amplicon sequencing will be performed on samples collected at baseline (before intervention, day -5), after 5 days of SPI supplementation (day 0), and after 10 days of GP-SPI supplementation (day 10). Total time frame is 17 days.</time_frame>
    <description>Evaluate the effect of nutritional supplementation with GP-SPI on gut microbiota composition by 16S rRNA amplicon sequencing and analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comprehensive Metabolic Panel (CMP) Blood Test (ALP, AST, ALT)</measure>
    <time_frame>Samples will be analyzed within one week of blood collection</time_frame>
    <description>Evaluate the effect of GP-SPI on kidney and liver health/function via CMP blood tests ALP, AST, ALT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comprehensive Metabolic Panel (CMP) Blood Test (Glucose, Blood Urea Nitrogen, Creatine, Calcium, Bilirubin Total)</measure>
    <time_frame>Samples will be analyzed within one week of blood collection</time_frame>
    <description>Evaluate the effect of GP-SPI on kidney and liver health/function via CMP blood tests Measure glucose, blood urea nitrogen, creatine, calcium, bilirubin total</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comprehensive Metabolic Panel (CMP) Blood Test (Anion Gap)</measure>
    <time_frame>Samples will be analyzed within one week of blood collection</time_frame>
    <description>Anion gap was measured for all 27 participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comprehensive Metabolic Panel (CMP) Blood Test (Sodium, Potassium, Chloride, Total Carbon Dioxide)</measure>
    <time_frame>Samples will be analyzed within one week of blood collection</time_frame>
    <description>CMP data was measured for all 27 participants (sodium, potassium, chloride, total carbon dioxide)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comprehensive Metabolic Panel (CMP) Blood Test (Protein, Albumin)</measure>
    <time_frame>Samples will be analyzed within one week of blood collection</time_frame>
    <description>Evaluate the effect of GP-SPI on kidney and liver health/function via CMP blood tests</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbiome-wide Association Study</measure>
    <time_frame>De-identified samples will be processed and analyzed after all subjects complete the study and within 1 year.</time_frame>
    <description>Collect fecal, blood, and urine samples for a microbiome-wide association study (MWAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Data Sharing</measure>
    <time_frame>Data will be deposited no later than within 1 year of the completion of the funded project period for the parent award or upon acceptance of the data for publication, or public disclosure of a submitted patent application</time_frame>
    <description>Enter de-identified study results into microbiome and metabolome nationwide data sharing database</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Mechanisms, Defense</condition>
  <arm_group>
    <arm_group_label>GP-SPI intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 g of GP-SPI taken twice per day for 10 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>GP-SPI</intervention_name>
    <description>grape polyphenol-soy protein isolate complex (GP-SPI)</description>
    <arm_group_label>GP-SPI intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Healthy as assessed based on a medical evaluation including a comprehensive metabolic&#xD;
             panel (CMP) test with values in normal range, medical history and not presently taking&#xD;
             any medication&#xD;
&#xD;
          2. Adults between 18 and 35 years&#xD;
&#xD;
          3. BMI 18.5 -29.9&#xD;
&#xD;
          4. Have at least one bowel movement per day&#xD;
&#xD;
          5. Capable of giving written informed consent, which includes compliance with the&#xD;
             requirements and restrictions listed in the consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. History/current cancer, rheumatoid arthritis immunologic, renal, hepatic, endocrine,&#xD;
             neurologic or heart disease, hypertension, diabetes, GI dysfunction, or CMP test&#xD;
             results showing values outside of normal range.&#xD;
&#xD;
          2. Cannot provide written informed consent.&#xD;
&#xD;
          3. Exposure to any experimental agent or procedure within 30 days of study.&#xD;
&#xD;
          4. Pregnancy or breast-feeding&#xD;
&#xD;
          5. Taking dietary supplements&#xD;
&#xD;
          6. Current smoker or have smoked within previous 6 months&#xD;
&#xD;
          7. Taking medications regularly (prescription, over the counter, supplements etc.)&#xD;
&#xD;
          8. Treated with antibiotics during the past 6 months&#xD;
&#xD;
          9. Have an allergy to soy or grapes&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diana Roopchand, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rutgers University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rutgers, The State University of New Jersey</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 8, 2019</study_first_submitted>
  <study_first_submitted_qc>July 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2019</study_first_posted>
  <results_first_submitted>July 29, 2021</results_first_submitted>
  <results_first_submitted_qc>October 12, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">November 10, 2021</results_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rutgers, The State University of New Jersey</investigator_affiliation>
    <investigator_full_name>Diana Roopchand, Ph.D.</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>gut microbiome</keyword>
  <keyword>metabolome</keyword>
  <keyword>dietary polyphenols</keyword>
  <keyword>grape</keyword>
  <keyword>nutrition</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 5, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/66/NCT04018066/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 5, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/66/NCT04018066/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>34 participants were enrolled in the study based on inclusion/exclusion criteria. 4 participants withdrawn from the study, due to the following reasons: 3 started taking medications and 1 had scheduling conflicts. Of the remaining 30 participants that completed the study, 3 were excluded due to protocol deviations.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>GP-SPI Intervention</title>
          <description>Each participant consumed 20 g of soy protein isolate (SPI) twice per day for 5 days. After a one day break, participants then consumed 20 g of GP-SPI taken twice per day for 10 days. During the entire 17 day study period, participants abstained from an extensive list of PAC-rich foods.&#xD;
GP-SPI: grape polyphenol-soy protein isolate complex (GP-SPI)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="34">34 participants were enrolled in the study</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30">30 participants completed the study protocol.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>participants started taking medications during the study period</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>participant dropped out due to schedule conflicts.</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>49 adults met initial inclusion/exclusion criteria. 11 people had CMP values outside normal ranges and 8 more people were excluded due to following reasons: 2 withdrew, 1 lost to follow up, 4 disqualified due to taking medication, 1 did not complete the study. 30 people completed study protocol, but 3 were excluded due to protocol deviations. 27 participants successfully completed the study protocol.</population>
      <group_list>
        <group group_id="B1">
          <title>GP-SPI Intervention</title>
          <description>Each participant consumed 20 g of soy protein isolate (SPI) twice per day for 5 days. After a one day break, participants then consumed 20 g of GP-SPI taken twice per day for 10 days. During the entire 17 day study period, participants abstained from an extensive list of PAC-rich foods.&#xD;
GP-SPI: grape polyphenol-soy protein isolate complex (GP-SPI)</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="27"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21.7" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Glucose</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="88.78" spread="6.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Blood urea nitrogen</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12.81" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Creatine</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.76" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Calcium</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9.82" spread="0.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sodium</title>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="142.7" spread="2.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Potassium</title>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.83" spread="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Chloride</title>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="103.4" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total carbon dioxide</title>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.04" spread="1.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Anion gap</title>
          <units>meq/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13.26" spread="2.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Protein</title>
          <units>g/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.38" spread="0.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Albumin</title>
          <units>g/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.83" spread="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Bilirubin total</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.54" spread="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Alkaline phosphatase</title>
          <units>IU/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68.56" spread="15.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Alkaline transaminase</title>
          <units>IU/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21.26" spread="5.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Alanine transaminase</title>
          <units>IU/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16.89" spread="7.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Gut Microbiota Composition</title>
        <description>Evaluate the effect of nutritional supplementation with GP-SPI on gut microbiota composition by 16S rRNA amplicon sequencing and analysis</description>
        <time_frame>16S rRNA amplicon sequencing will be performed on samples collected at baseline (before intervention, day -5), after 5 days of SPI supplementation (day 0), and after 10 days of GP-SPI supplementation (day 10). Total time frame is 17 days.</time_frame>
        <population>All 27 participant samples were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>GP-SPI Intervention</title>
            <description>Each participant consumed 20 g of soy protein isolate (SPI) twice per day for 5 days. After a one day break, participants then consumed 20 g of GP-SPI taken twice per day for 10 days. During the entire 17 day study period, participants abstained from an extensive list of PAC-rich foods.&#xD;
GP-SPI: grape polyphenol-soy protein isolate complex (GP-SPI)</description>
          </group>
        </group_list>
        <measure>
          <title>Gut Microbiota Composition</title>
          <description>Evaluate the effect of nutritional supplementation with GP-SPI on gut microbiota composition by 16S rRNA amplicon sequencing and analysis</description>
          <population>All 27 participant samples were analyzed.</population>
          <units>percentage of bacterial phyla</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Firmicutes (day -5), % relative abundance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bacteroidetes (day -5), % relative abundance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30" spread="9.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Verrucomicrobia (day -5), % relative abundance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Actinobacteria (day -5), % relative abundance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.3" spread="5.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Proteobacteria (day -5), % relative abundance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tenericutes (day -5), % relative abundance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Firmicutes (day 0), % relative abundance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.3" spread="6.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bacteroidetes (day 0), % relative abundance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.1" spread="8.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Verrucomicrobia (day 0), % relative abundance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Actinobacteria (day 0), % relative abundance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.29" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Proteobacteria (day 0), % relative abundance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.66" spread="2.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tenericutes (day 0), % relative abundance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.009" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Firmicutes (day 10), % relative abundance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.3" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bacteroidetes (day 10), % relative abundance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.44" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Verrucomicrobia (day 10), % relative abundance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Actinobacteria (day 10), % relative abundance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.1" spread="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Proteobacteria (day 10), % relative abundance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tenericutes (day 10), % relative abundance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comprehensive Metabolic Panel (CMP) Blood Test (ALP, AST, ALT)</title>
        <description>Evaluate the effect of GP-SPI on kidney and liver health/function via CMP blood tests ALP, AST, ALT</description>
        <time_frame>Samples will be analyzed within one week of blood collection</time_frame>
        <population>CMP data was measured for all 27 participants</population>
        <group_list>
          <group group_id="O1">
            <title>GP-SPI Intervention</title>
            <description>20 g of GP-SPI taken twice per day for 10 days&#xD;
GP-SPI: grape polyphenol-soy protein isolate complex (GP-SPI)</description>
          </group>
        </group_list>
        <measure>
          <title>Comprehensive Metabolic Panel (CMP) Blood Test (ALP, AST, ALT)</title>
          <description>Evaluate the effect of GP-SPI on kidney and liver health/function via CMP blood tests ALP, AST, ALT</description>
          <population>CMP data was measured for all 27 participants</population>
          <units>IU/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Alkaline phosphatase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.7" spread="16.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aspartate transaminase (IU/L)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.41" spread="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Alkaline transaminase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.52" spread="8.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comprehensive Metabolic Panel (CMP) Blood Test (Glucose, Blood Urea Nitrogen, Creatine, Calcium, Bilirubin Total)</title>
        <description>Evaluate the effect of GP-SPI on kidney and liver health/function via CMP blood tests Measure glucose, blood urea nitrogen, creatine, calcium, bilirubin total</description>
        <time_frame>Samples will be analyzed within one week of blood collection</time_frame>
        <population>CMP data was measured for all 27 participants</population>
        <group_list>
          <group group_id="O1">
            <title>GP-SPI Intervention</title>
            <description>20 g of GP-SPI taken twice per day for 10 days&#xD;
GP-SPI: grape polyphenol-soy protein isolate complex (GP-SPI)</description>
          </group>
        </group_list>
        <measure>
          <title>Comprehensive Metabolic Panel (CMP) Blood Test (Glucose, Blood Urea Nitrogen, Creatine, Calcium, Bilirubin Total)</title>
          <description>Evaluate the effect of GP-SPI on kidney and liver health/function via CMP blood tests Measure glucose, blood urea nitrogen, creatine, calcium, bilirubin total</description>
          <population>CMP data was measured for all 27 participants</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Glucose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.96" spread="6.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Blood urea nitrogen</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.81" spread="3.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.76" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Calcium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.64" spread="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bilirubin total</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.54" spread="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comprehensive Metabolic Panel (CMP) Blood Test (Anion Gap)</title>
        <description>Anion gap was measured for all 27 participants</description>
        <time_frame>Samples will be analyzed within one week of blood collection</time_frame>
        <population>CMP data was measured for all 27 participants</population>
        <group_list>
          <group group_id="O1">
            <title>GP-SPI Intervention</title>
            <description>20 g of GP-SPI taken twice per day for 10 days&#xD;
GP-SPI: grape polyphenol-soy protein isolate complex (GP-SPI)</description>
          </group>
        </group_list>
        <measure>
          <title>Comprehensive Metabolic Panel (CMP) Blood Test (Anion Gap)</title>
          <description>Anion gap was measured for all 27 participants</description>
          <population>CMP data was measured for all 27 participants</population>
          <units>meq/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.41" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comprehensive Metabolic Panel (CMP) Blood Test (Sodium, Potassium, Chloride, Total Carbon Dioxide)</title>
        <description>CMP data was measured for all 27 participants (sodium, potassium, chloride, total carbon dioxide)</description>
        <time_frame>Samples will be analyzed within one week of blood collection</time_frame>
        <population>CMP data was measured for all 27 participants</population>
        <group_list>
          <group group_id="O1">
            <title>GP-SPI Intervention</title>
            <description>20 g of GP-SPI taken twice per day for 10 days&#xD;
GP-SPI: grape polyphenol-soy protein isolate complex (GP-SPI)</description>
          </group>
        </group_list>
        <measure>
          <title>Comprehensive Metabolic Panel (CMP) Blood Test (Sodium, Potassium, Chloride, Total Carbon Dioxide)</title>
          <description>CMP data was measured for all 27 participants (sodium, potassium, chloride, total carbon dioxide)</description>
          <population>CMP data was measured for all 27 participants</population>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Sodium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="142.2" spread="2.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Potassium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.57" spread="0.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chloride</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="102.3" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total carbon dioxide</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.51" spread="1.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comprehensive Metabolic Panel (CMP) Blood Test (Protein, Albumin)</title>
        <description>Evaluate the effect of GP-SPI on kidney and liver health/function via CMP blood tests</description>
        <time_frame>Samples will be analyzed within one week of blood collection</time_frame>
        <population>CMP data was measured for all 27 participants</population>
        <group_list>
          <group group_id="O1">
            <title>GP-SPI Intervention</title>
            <description>20 g of GP-SPI taken twice per day for 10 days&#xD;
GP-SPI: grape polyphenol-soy protein isolate complex (GP-SPI)</description>
          </group>
        </group_list>
        <measure>
          <title>Comprehensive Metabolic Panel (CMP) Blood Test (Protein, Albumin)</title>
          <description>Evaluate the effect of GP-SPI on kidney and liver health/function via CMP blood tests</description>
          <population>CMP data was measured for all 27 participants</population>
          <units>g/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Protein</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.37" spread="0.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Albumin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.87" spread="0.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Microbiome-wide Association Study</title>
        <description>Collect fecal, blood, and urine samples for a microbiome-wide association study (MWAS)</description>
        <time_frame>De-identified samples will be processed and analyzed after all subjects complete the study and within 1 year.</time_frame>
        <posting_date>12/2021</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Data Sharing</title>
        <description>Enter de-identified study results into microbiome and metabolome nationwide data sharing database</description>
        <time_frame>Data will be deposited no later than within 1 year of the completion of the funded project period for the parent award or upon acceptance of the data for publication, or public disclosure of a submitted patent application</time_frame>
        <posting_date>12/2021</posting_date>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>20 days</time_frame>
      <desc>An adverse event (AE) is any untoward medical occurrence in a subject during participation in the clinical study or with use of the experimental agent being studied. An adverse finding can include a sign, symptom, abnormal assessment (laboratory test value, vital signs, electrocardiogram finding, etc.), or any combination of these regardless of relationship to participation in the study.</desc>
      <group_list>
        <group group_id="E1">
          <title>GP-SPI Intervention</title>
          <description>Each participant consumed 20 g of soy protein isolate (SPI) twice per day for 5 days. After a one day break, participants then consumed 20 g of GP-SPI taken twice per day for 10 days. During the entire 17 day study period, participants abstained from an extensive list of PAC-rich foods.&#xD;
GP-SPI: grape polyphenol-soy protein isolate complex (GP-SPI)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Diana Roopchand, Study Investigator</name_or_title>
      <organization>Rutgers, The State University of New Jersey</organization>
      <phone>8489320248</phone>
      <email>roopchand@sebs.rutgers.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

